Sign up to save your podcasts
Or
Share Medical Cannabis: Oncology and Pain Game Changer, or just a Pipe Dream? With OCT Founders Gavin Sathianathan and Neil Mahapatra.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Medical Cannabis: Oncology and Pain Game Changer, or just a Pipe Dream? With OCT Founders Gavin Sathianathan and Neil Mahapatra.
Medical cannabis is expected to reach 56.7B market value by 2026. On this episode we hear from Oxford Cannabinoid Technologies co-founders Neil Mahapatra (Kingsley Capital Partners, Rothschild, Morgan Stanley) and Gavin Sathianathan (Alta Flora, Facebook, Bain) about their use of technological advances and a network innovation model to develop patient-saving pharmaceuticals from cannabis.
Music from: https://freesound.org/
OCT: https://www.oxcantech.com/
View all episodes
By oxfordbiotechpodcastMedical cannabis is expected to reach 56.7B market value by 2026. On this episode we hear from Oxford Cannabinoid Technologies co-founders Neil Mahapatra (Kingsley Capital Partners, Rothschild, Morgan Stanley) and Gavin Sathianathan (Alta Flora, Facebook, Bain) about their use of technological advances and a network innovation model to develop patient-saving pharmaceuticals from cannabis.
Music from: https://freesound.org/
OCT: https://www.oxcantech.com/